These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1356986)

  • 1. Characterization of the azidopine and vinblastine binding site of P-glycoprotein.
    Bruggemann EP; Currier SJ; Gottesman MM; Pastan I
    J Biol Chem; 1992 Oct; 267(29):21020-6. PubMed ID: 1356986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two different regions of P-glycoprotein [corrected] are photoaffinity-labeled by azidopine.
    Bruggemann EP; Germann UA; Gottesman MM; Pastan I
    J Biol Chem; 1989 Sep; 264(26):15483-8. PubMed ID: 2475500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoaffinity probes for the alpha 1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein.
    Greenberger LM; Yang CP; Gindin E; Horwitz SB
    J Biol Chem; 1990 Mar; 265(8):4394-401. PubMed ID: 1968459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.
    Abraham I; Wolf CL; Sampson KE
    Cancer Chemother Pharmacol; 1993; 32(2):116-22. PubMed ID: 8097968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line.
    Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S
    Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of P-glycoprotein with a hydrophobic component of rat urine.
    Charuk JH; Reithmeier RA
    Biochem Biophys Res Commun; 1992 Jul; 186(2):796-802. PubMed ID: 1353959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
    Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
    Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 1993 Sep; 268(27):19965-72. PubMed ID: 8104183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic orientation and two-domain structure of the multidrug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies.
    Yoshimura A; Kuwazuru Y; Sumizawa T; Ichikawa M; Ikeda S; Uda T; Akiyama S
    J Biol Chem; 1989 Sep; 264(27):16282-91. PubMed ID: 2476441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional consequences of proline mutations in the predicted transmembrane domain of P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 1993 Feb; 268(5):3143-9. PubMed ID: 8094081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance.
    Zordan-Nudo T; Ling V; Liu Z; Georges E
    Cancer Res; 1993 Dec; 53(24):5994-6000. PubMed ID: 7903200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation of P-glycoprotein transport by protein kinase inhibition.
    Bates SE; Lee JS; Dickstein B; Spolyar M; Fojo AT
    Biochemistry; 1993 Sep; 32(35):9156-64. PubMed ID: 7690250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
    Safa AR; Agresti M; Bryk D; Tamai I
    Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of P-glycoprotein mutants identifies predicted transmembrane domain 11 as a putative drug binding site.
    Kajiji S; Talbot F; Grizzuti K; Van Dyke-Phillips V; Agresti M; Safa AR; Gros P
    Biochemistry; 1993 Apr; 32(16):4185-94. PubMed ID: 7682843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.
    Yang CP; DePinho SG; Greenberger LM; Arceci RJ; Horwitz SB
    J Biol Chem; 1989 Jan; 264(2):782-8. PubMed ID: 2562956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azidopine photoaffinity labeling of multidrug resistance-associated glycoproteins.
    Yang CP; Mellado W; Horwitz SB
    Biochem Pharmacol; 1988 Apr; 37(7):1417-21. PubMed ID: 2895656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.